Brain

Genova Diagnostics Partners with Neurocode to Launch Innovative Alzheimer’s Assessment

ASHEVILLE, N.C., Aug. 9, 2024 /PRNewswire/ -- Genova Diagnostics, a global leader in clinical laboratory services, proudly announces the launch of…

2 years ago

Awakn Announces First Patient Screened in Phase 3 Clinical Trial of AWKN-001 for Severe Alcohol Use Disorder

Toronto, Ontario--(Newsfile Corp. - August 9, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

2 years ago

WorkFar Robotics Unleashes Sentient Humanoid Robots “Syntro” into the WorkForce

WorkFar Robotics' sentient humanoid "Syntro" is a sophisticated, AI-enhanced robot in human form that can be effortlessly controlled by a…

2 years ago

MEDFAR, Fastest-growing EMR/EHR Provider, Announces Successful Entry Into the U.S. Primary Care Market with COMTRON Integration

MEDFAR Unveils New Brand Identity Reflecting Its Growth and Ambitious Healthcare Goals MONTREAL, Aug. 8, 2024 /PRNewswire/ - MEDFAR, developer…

2 years ago

Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing

The potential addressable market opportunity for ONP-002 includes an estimated 69 million concussions globallySARASOTA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE)…

2 years ago

Natus introduces autoSCORE, an innovative AI solution capable of a new era of expert-level clinical EEG interpretation

MIDDLETON, Wis., Aug. 7, 2024 /PRNewswire/ -- Natus Medical Incorporated has announced the launch of autoSCORE, the first-of-its-kind artificial intelligence…

2 years ago

LabCentral Launches “The Dish with Johannes” Video Series Profiling Biotech Entrepreneurs and Scientists Shaping the Industry’s Future

CAMBRIDGE, Mass., Aug. 7, 2024 /PRNewswire/ --  LabCentral, the premier Massachusetts-based network of coworking labs designed to accelerate high-potential biotech startups, launched…

2 years ago

Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

Silo to advance homing peptide development for initial indication in multiple sclerosis SARASOTA, FL, Aug. 07, 2024 (GLOBE NEWSWIRE) --…

2 years ago

Inhibikase Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024

BOSTON and ATLANTA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical…

2 years ago